Aeterna Zentaris Inc. (AEZS)

1 member of Congress has disclosed 6 trades in Aeterna Zentaris Inc. (AEZS) via STOCK Act filings. The most recent disclosure was a sale by Roger Marshall on 20 July 2017. Aggregate disclosed activity totals roughly $24K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for AEZS
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for AEZS

5 transactions
Compliance: 0%
Roger Marshall20 Jul 201713 Aug 2020SaleStock$1,001 - $15,000N/A
Roger Marshall20 Jul 201710 Aug 2018SaleStock$1,001 - $15,000N/A
Roger Marshall20 Jul 20176 Aug 2018SaleStock$1,001 - $15,000N/A
Roger Marshall19 Jul 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall19 Jul 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$17.51M

Volume

7.51K

Beta

2.26

P/E Ratio

-2.48

Fundamentals

EPS

$-2.31

Div. Yield

-

Open

$5.50

Day Range

$5.48 – $5.93

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Gilles R. Gagnon
IPO Date
2000-05-10

Aeterna Zentaris Inc. operates as a specialized biopharmaceutical company, dedicated to the creation and market introduction of both therapeutic drugs and diagnostic tests. Its flagship product, macimorelin, is an orally administered peptidomimetic g...

Earnings

Recent Quarters

Q2 202511 Aug
EPS-
Q1 202512 May
EPS-
Q4 202425 Mar
EPS-
Q3 20247 Nov
EPS-
Q2 202413 Aug
EPS$-2.08
Q1 202414 May
EPS$-4.74
Miss 485.2%
Q4 202327 Mar
EPS$-4.64
Miss 19.6%
Q3 20239 Nov
EPS$-3.40
Miss 39.3%
Q2 20239 Aug
EPS$-2.08
Beat 40.2%
Q1 20239 May
EPS$-3.52
Beat 17.8%
Q4 202223 Mar
EPS$-3.36
Beat 9.7%
Q3 20223 Nov
EPS$-2.80
Miss 2.9%
Q2 20223 Aug
EPS$-3.48
Miss 27.9%
Q1 202210 May
EPS$-2.00
Beat 0.0%
Q4 202128 Mar
EPS$-2.00
Beat 0.0%
Q3 20214 Nov
EPS$-1.00
Beat 50.0%
Q2 20214 Aug
EPS$-2.00
Q1 20215 May
EPS$-2.00
Q4 202024 Mar
EPS$-2.00
Q3 20205 Nov
EPS$-2.00
Q2 20206 Aug
EPS$-15.00
Q1 20206 May
EPS$4.00
Q4 201930 Mar
EPS$-5.00
Q3 20197 Nov
EPS$-2.00
Beat 88.2%
Q2 201913 Aug
EPS$1.00
Beat 107.1%
Q1 20197 May
EPS$-14.00
Miss 450.0%
Q4 201826 Mar
EPS$-31.00
Miss 63.2%
Q3 20186 Nov
EPS$-15.00
Beat 40.0%
Q2 20189 Aug
EPS$-16.00
Beat 50.0%
Q1 20187 May
EPS$87.00
Beat 1066.7%
Q4 201728 Mar
EPS$-24.00
Beat 35.1%
Q3 20178 Nov
EPS$-44.00
Miss 7.3%
Q2 201710 Aug
EPS$-46.00
Miss 12.2%
Q1 20178 May
EPS$-31.00
Beat 6.1%
Q4 201615 Mar
EPS$-71.00
Beat 16.5%
Q3 20168 Nov
EPS$-61.00
Beat 17.6%
Q2 20169 Aug
EPS$-71.00
Beat 40.3%
Q1 20169 May
EPS$-37.00
Beat 73.9%
Q4 201529 Mar
EPS$-146.00
Miss 5.0%
Q3 20155 Nov
EPS$-700.00
Miss 40.0%
Q2 201513 Aug
EPS$-1400.00
Miss 75.0%
Q1 20157 May
EPS$-1300.00
Miss 18.2%
Q4 201417 Mar
EPS$600.00
Beat 133.3%
Q3 20144 Nov
EPS$-2000.00
Miss 400.0%
Q2 20147 Aug
EPS$-900.00
Miss 89.5%
Q1 20148 May
EPS$-800.00
Miss 6.7%
Q4 201320 Mar
EPS$-2800.00
Miss 3100.0%
Q3 20135 Nov
EPS$1300.00
Beat 150.0%
Q2 20138 Aug
EPS$3700.00
Beat 232.1%
Q1 20137 May
EPS$700.00
Beat 124.1%
Q4 201221 Mar
EPS$-2900.00
Beat 21.6%
Q3 201213 Nov
EPS$-3500.00
Beat 20.4%
Q2 201214 Aug
EPS$600.00
Beat 169.0%
Q1 20129 May
EPS$-1650.00
Miss 26.9%
Q4 201127 Mar
EPS$-1050.00
Beat 24.6%
Q3 201110 Nov
EPS$300.00
Beat 122.2%
Q2 201110 Aug
EPS$-1800.00
Miss 57.4%
Q1 201118 May
EPS$-1800.00
Miss 57.9%
Q4 201022 Mar
EPS$-450.00
Beat 59.5%
Q3 20109 Nov
EPS$-1800.00
Miss 26.3%
Q2 201012 Aug
EPS$-900.00
Beat 37.9%
Q1 201013 May
EPS$-1350.00
Beat 27.0%
Q4 200924 Mar
EPS$2850.00
Beat 207.6%
Q3 200911 Nov
EPS$-2850.00
Beat 10.6%
Q2 200911 Aug
EPS$-3600.00
Miss 4.3%
Q1 20096 May
EPS$-3450.00
Miss 39.4%
Q4 200811 Mar
EPS$-4050.00
Miss 5.2%
Q3 200813 Nov
EPS$-3900.00
Beat 6.3%
Q2 200812 Aug
EPS$-5850.00
Miss 48.9%
Q1 20087 May
EPS$-3000.00
Beat 15.2%
Q4 20075 Mar
EPS$-3900.00
Miss 38.0%
Q3 20077 Nov
EPS$-2400.00
Miss 31.5%
Q2 200713 Aug
EPS$-1350.00
Beat 29.7%
Q1 20072 May
EPS$-1500.00
Beat 16.7%
Q4 20065 Mar
EPS$10500.00
Beat 366.7%
Q3 200613 Nov
EPS$-1800.00
Miss 220.0%
Q2 200611 Aug
EPS$-450.00
Miss 250.0%
Q1 20063 May
EPS$-750.00
Miss 336.5%
Q4 20051 Mar
EPS$300.00
Beat 156.9%
Q3 200514 Nov
EPS$-1200.00
Miss 58.8%
Q2 20055 Aug
EPS$4296.53
Q2 20053 Aug
EPS$210.00
Beat 3600.0%
Q4 200428 Feb
EPS$-36.00
Miss 1300.0%
Q3 20045 Nov
EPS$-24.00
Beat 42.9%
Q2 200411 Aug
EPS$18.00
Q1 20044 May
EPS$-36.00
Miss 20.0%
Q4 200327 Feb
EPS$-126.00
Beat 14.3%
Q3 20035 Nov
EPS$-120.00
Miss 66.7%
Q2 20036 Aug
EPS$-66.00
Beat 24.1%
Q1 200330 Apr
EPS$-72.00
Miss 9.1%
Q4 200220 Feb
EPS$-120.00
Miss 29.0%
Q3 200222 Oct
EPS$-90.00
Beat 14.9%
Q2 200230 Sept
EPS$-1454.20
Q1 200217 Apr
EPS$-102.00
Miss 7.6%
Q4 200119 Feb
EPS$-48.00
Beat 55.6%
Q3 200131 Dec
EPS$-819.36
Q1 200130 Jun
EPS$2379.44
Q4 200031 Mar
EPS$-1025.87
Q3 200031 Dec
EPS$-1382.43
Q2 200030 Sept
EPS$761.94
Q1 200030 Jun
EPS$-683.29
Q4 199931 Mar
EPS$1796.31
Q3 199931 Dec
EPS$677.84
Q2 199930 Sept
EPS$-715.02
Q1 199930 Jun
EPS$-813.85
Q4 199831 Mar
EPS$-695.65
Q3 199831 Dec
EPS$-341.22
Q2 199830 Sept
EPS$-294.76
Q1 199830 Jun
EPS$-306.27

6 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

7 Jun 2024Reverse Split
Ratio59:2500
21 Jul 2022Reverse Split
Ratio1:25
20 Nov 2015Reverse Split
Ratio1:100
5 Oct 2012Reverse Split
Ratio1:6

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about AEZS

Which members of Congress have traded AEZS?
1 member of Congress has disclosed 6 trade in Aeterna Zentaris Inc. (AEZS) under the STOCK Act: Roger Marshall.
When was AEZS most recently disclosed by Congress?
The most recent AEZS disclosure was a sale by Roger Marshall on 20 July 2017.
What is the total disclosed congressional trading volume for AEZS?
Members of Congress have disclosed approximately $24K in AEZS purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AEZS?
This AEZS page updates as soon as new STOCK Act disclosures are filed for Aeterna Zentaris Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.